These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 10344762

  • 21. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
    Cinatl J, Kotchetkov R, Blaheta R, Driever PH, Vogel JU, Cinatl J.
    Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
    [Abstract] [Full Text] [Related]

  • 22. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
    Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A.
    Oncogene; 2000 Feb 03; 19(5):617-23. PubMed ID: 10698506
    [Abstract] [Full Text] [Related]

  • 23. retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines.
    Cerignoli F, Guo X, Cardinali B, Rinaldi C, Casaletto J, Frati L, Screpanti I, Gudas LJ, Gulino A, Thiele CJ, Giannini G.
    Cancer Res; 2002 Feb 15; 62(4):1196-204. PubMed ID: 11861404
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ectopic expression of DAN enhances the retinoic acid-induced neuronal differentiation in human neuroblastoma cell lines.
    Nakamura Y, Ozaki T, Ichimiya S, Nakagawara A, Sakiyama S.
    Biochem Biophys Res Commun; 1998 Feb 24; 243(3):722-6. PubMed ID: 9500977
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.
    Ricaud S, Vernus B, Bonnieu A.
    Exp Cell Res; 2005 Dec 10; 311(2):192-204. PubMed ID: 16236281
    [Abstract] [Full Text] [Related]

  • 28. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.
    Abe N, Watanabe T, Sugiyama M, Uchimura H, Chiappetta G, Fusco A, Atomi Y.
    Cancer Res; 1999 Mar 15; 59(6):1169-74. PubMed ID: 10096541
    [Abstract] [Full Text] [Related]

  • 29. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
    Abemayor E.
    Laryngoscope; 1992 Oct 15; 102(10):1133-49. PubMed ID: 1328787
    [Abstract] [Full Text] [Related]

  • 30. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis.
    Tkachenko A, Ashar HR, Meloni AM, Sandberg AA, Chada KK.
    Cancer Res; 1997 Jun 01; 57(11):2276-80. PubMed ID: 9187132
    [Abstract] [Full Text] [Related]

  • 31. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP.
    Clin Cancer Res; 2000 May 01; 6(5):1900-8. PubMed ID: 10815914
    [Abstract] [Full Text] [Related]

  • 32. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ.
    Cancer Res; 1995 Apr 15; 55(8):1798-806. PubMed ID: 7712490
    [Abstract] [Full Text] [Related]

  • 33. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
    Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A, Verde P.
    EMBO J; 1997 Sep 01; 16(17):5310-21. PubMed ID: 9311991
    [Abstract] [Full Text] [Related]

  • 34. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A.
    Cancer Res; 1998 Sep 15; 58(18):4193-8. PubMed ID: 9751634
    [Abstract] [Full Text] [Related]

  • 35. Insulin-like growth factor binding protein 5: contribution to growth and differentiation of neuroblastoma cells.
    Cesi V, Vitali R, Tanno B, Giuffrida ML, Sesti F, Mancini C, Raschellà G.
    Ann N Y Acad Sci; 2004 Dec 15; 1028():59-68. PubMed ID: 15650232
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.
    Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J.
    Am J Pathol; 1996 Sep 15; 149(3):775-9. PubMed ID: 8780382
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines.
    Strippoli P, Bagnara GP, Montanaro L, Timeus F, Ferreri AM, Rocchi P.
    Anticancer Res; 2000 Sep 15; 20(6B):4361-6. PubMed ID: 11205272
    [Abstract] [Full Text] [Related]

  • 40. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G, Brandmaier P, Scholz G, Ackermann OP, Alt R, Rothe K, Cross M, Witzigmann H, Tröbs RB.
    J Pediatr Surg; 2008 Jul 15; 43(7):1284-94. PubMed ID: 18639684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.